Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
MRNA on Nasdaq
Noubar Afeyan - trading volume in the past year for Moderna, Inc.
Holdings reported by Noubar Afeyan for Moderna, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
3.88M |
$472M |
$121.62 |
Jul 31, 2024 |
By Flagship Ventures Fund IV, L.P. |
|
|
Common Stock |
2.22M |
$270M |
$121.62 |
Jul 31, 2024 |
Direct |
|
|
Common Stock |
748K |
$91M |
$121.62 |
Jul 31, 2024 |
By Flagship Ventures Fund IV-Rx, L.P. |
|
|
Common Stock |
3.92K |
$477K |
$121.62 |
Jul 31, 2024 |
By Flagship Pioneering, Inc. |
|
|
Stock Option (Right to Buy) |
7.56K |
|
|
May 6, 2024 |
Direct |
Common Stock |
|
Transactions reported by Noubar Afeyan for Moderna, Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.